THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death
Clinical trial NCT03354429 · COMPLETED
Trial details
- NCT number
- NCT03354429
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-22
- Primary completion
- 2019-12-13
- Enrollment
- 11016
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.